Back to Search
MARY MAROVICH, M.D.
M.D.
Infectious Disease Physician
NPI: 1871657783Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
D0061003(MD)
Research & Publications (20)
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.
PMID 19654066·Vaccine·2009
7-preclinical
Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection.
PMID 19487954·J Acquir Immune Defic Syndr·2009
8-other
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.
PMID 19450647·Vaccine·2009
3-trial
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity.
PMID 19450644·Vaccine·2009
2-rct
Increased African-American involvement in vaccine studies.
PMID 19095169·J Clin Epidemiol·2009
8-other
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus.
PMID 19013627·Virology·2009
4-observational
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.
PMID 18808335·J Infect Dis·2008
3-trial
Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
PMID 18272578·J Virol·2008
8-other
Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment.
PMID 18077621·Clin Vaccine Immunol·2008
8-other
Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.
PMID 17506610·AIDS Res Hum Retroviruses·2007
8-other
Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.
PMID 17409140·J Virol·2007
4-observational
CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cell-mediated immunopathology.
PMID 17056582·J Immunol·2006
8-other
An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies.
PMID 16417930·J Virol Methods·2006
7-preclinical
HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
PMID 15990569·AIDS·2005
4-observational
Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.
PMID 15827168·J Virol·2005
4-observational
Differential effects of dengue virus on infected and bystander dendritic cells.
PMID 15681444·J Virol·2005
7-preclinical
Specific antibody production by blood B cells is retained in late stage drug-naïve HIV-infected Africans.
PMID 15330447·Clin Dev Immunol·2004
8-other
ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development.
PMID 15285709·Expert Rev Vaccines·2004
6-review
Identification of germinal center B cells in blood from HIV-infected drug-naive individuals in Central Africa.
PMID 15154608·Clin Dev Immunol·2004
8-other
Isotype profiles of anti-gp160 antibodies from HIV-infected patients in plasma and culture supernatants.
PMID 15134900·Immunol Lett·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2 WRAMC DEPARTMENT, 6900 GEORGIA AVE NW
WASHINGTON, DC 20307 - Phone
- (202) 782-6205
Quick Facts
- NPI
- 1871657783
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile